As flagged by one of the profs, FDA has asked for some additional info and so the 5 August response date by FDA has been pushed out. Still expecting a decision from the FDA in this current September quarter.
Also cash balance is tight. If not for a bunch of options being exercised during the June quarter the company would have been up the creek. I guess they are waiting for FDA approval before raising some much needed capital. Baited breath stuff.
Ann: Quarterly Activities Report and Appendix 4C Cash Flow Report, page-3
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
24.0¢ |
Change
0.010(4.35%) |
Mkt cap ! $154.8M | |||
| Open | High | Low | Value | Volume |
| 23.0¢ | 24.0¢ | 23.0¢ | $140.4K | 600.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 224532 | 23.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 24.0¢ | 70915 | 3 |
View Market Depth
| Last trade - 16.10pm 23/07/2025 (20 minute delay) ? |
| EIQ (ASX) Chart |